TLDR
- Cathie Wood’s ARK Invest acquired 934,968 Anthropic shares across six ETFs during the company’s Nasdaq debut.
- ARK Invest’s Anthropic holdings reached approximately $90.9 million in market value by Thursday’s closing session.
- Anthropic shares closed at $97.17, above their $83 IPO price but below the $111.50 opening price.
- ARK Innovation ETF led the purchases with 556,777 shares, representing the largest allocation among six funds.
- Meanwhile, ARK Invest sold 33,430 Nvidia shares while expanding its exposure to Anthropic.
Cathie Wood’s ARK Invest acquired 934,968 Anthropic shares during the company’s November 19 Nasdaq debut. The stake reached approximately $90.9 million in market value by Thursday’s close. The purchase placed Anthropic in all six of ARK’s actively managed exchange-traded funds.
ARK Innovation ETF led the buying with 556,777 shares, the largest allocation by share count. Meanwhile, ARK Next Generation Internet ETF added 146,183 shares, extending the purchase across another technology-focused portfolio. ARK Autonomous Technology and Robotics ETF purchased 90,923 shares, according to the firm’s disclosed trading activity.
ARK Genomic Revolution ETF acquired 77,782 shares, while ARK Fintech Innovation ETF bought another 38,729. The ARK Space Exploration and Innovation ETF added 24,574 shares, completing the six-fund purchase. These positions represented less than one percent of each fund’s assets at Thursday’s close.
Anthropic Debut Follows Record IPO Pricing
Anthropic entered public trading under the ticker ANT after pricing its initial offering at $83 per share. Its November 18 SEC filing listed 980 million shares and an $81.34 billion offering. The transaction surpassed SpaceX’s June listing and established a new record for an initial public offering.
Anthropic opened at $111.50, well above its offering price, before losing ground during the session. Shares finished Thursday at $97.17, roughly 13% below the opening trade but above the IPO price. That closing figure values ARK’s new holdings near $90.9 million, rather than confirming their original acquisition cost.
Demand had already exceeded available shares by roughly six times during the book-building process. Earlier coverage of the share offering described that demand before the final IPO price emerged. Separately, Anthropic arranged a $26 billion private placement alongside the public offering, according to regulatory documents.
ARK Cuts Nvidia Exposure During Portfolio Changes
ARK also reduced its Nvidia stake on Thursday, selling 33,430 shares through its robotics-focused fund. The chipmaker’s shares carried a closing market value of approximately $4.9 million for that transaction. However, the trading disclosure did not identify the Anthropic purchase as the reason for Nvidia’s sale.
The firm also sold 93,430 Adaptive Biotechnologies shares and 28,095 CareDx shares across its health-focused holdings. At the same time, ARK added shares of GeneDx, Twist Bioscience, and Kodiak. These transactions accompanied the new Anthropic allocation but involved different companies and business sectors.
ARK previously expanded positions in other newly listed technology businesses, including SpaceX during its June market debut. Its earlier purchases of technology stocks also included Nvidia and Circle during August. Despite Thursday’s additions, Anthropic remained outside ARK’s ten largest positions by total portfolio value.







